Royalty Security

Royalty Security, LLC is a specialized investment vehicle and wholly owned subsidiary of BVF Partners, L.P. (Biotechnology Value Fund). The company primarily engages in royalty financing and the acquisition of royalty interests from biotechnology and pharmaceutical firms to provide them with non-dilutive capital. It is notably involved in the funding and royalty rights for patidegib (also known as SGT-610), a Hedgehog pathway inhibitor, through strategic agreements with Infinity Pharmaceuticals and PellePharm. Royalty Security acts as a financial partner within the life sciences sector, securing its investments through formal royalty security agreements and intellectual property licensing.